NORWAY → NORTH AMERICA

From Norwegian research to a credible U.S. commercial pathway.

Nordmark advances Norwegian research and IP toward U.S. validation and commercial partnerships.

Strong research can still be difficult to commercialize across borders.

Promising technologies can be too early, specialized or disconnected from U.S. markets for conventional investors and partners to assess efficiently. Nordmark focuses on that gap.

Market Relevance

Clarify the highest-value U.S. use cases and who may care.

Validation Evidence

Define what technical and market proof decision-makers need next.

Commercial Path

Select the right route—license, partnership, co-development or venture.

Start with the IP—not a preset vehicle.

A promising technology does not automatically need a startup. Its strongest next step may be validation, licensing, distribution, co-development or a strategic partnership. Nordmark begins with the technology and market need; structure follows the opportunity.

How Nordmark Works

01 — Discover

01 — Discover

01 — Discover

Engage researchers, institutions and IP owners around a defined technology and its commercial context.

02 — Assess

01 — Discover

01 — Discover

Examine differentiation, rights, readiness, market need and fit for North American pathways.

03 — Validate

01 — Discover

04 — Agree the Path

Test priority U.S. use cases and engage prospective strategic or validation partners.

04 — Agree the Path

04 — Agree the Path

04 — Agree the Path

Define roles, rights, milestones, capital needs and aligned economics.

05 — Commercialize

04 — Agree the Path

05 — Commercialize

Advance the strongest next step—pilot, license, distribution, strategic partnership, co-development or venture only when justified.

For Researchers & IP Holders

A practical U.S. pathway, built around the technology. Nordmark works with researchers, universities, hospitals, institutes and technology-transfer organizations to assess whether selected IP has a credible North American commercial path.

We identify the strongest U.S. use cases, relevant validation environments and strategic partners.

We clarify the evidence, rights and structure needed for the next commercial step.

For Investors & Capital Partners

Nordmark is building earlier visibility into selected Norwegian research and IP—before it becomes conventional venture deal flow. We assess the opportunity, test U.S. relevance and define the commercial pathway before capital is deployed.

Earlier Access

Visibility into selected university and research-based IP at an earlier stage.

Capital Behind Evidence

Funding follows defined diligence, validation needs and commercial milestones.

Flexible Paths to Value

Licensing, partnership, co-development or venture—supported by Nordic and U.S. capital where appropriate.

About Nordmark

Nordmark Technologies

Nordmark Technologies

Nordmark Technologies

A U.S.-based commercialization partner connecting selected Norwegian research and intellectual property with North American market pathways.

Mark Jansa

Nordmark Technologies

Nordmark Technologies

Managing Partner. Strategy, business development and venture leader with more than 30 years shaping new opportunities. Mark leads sourcing, U.S. market validation,  and strategic relationships.

Kent Rodriguez

Nordmark Technologies

Kent Rodriguez

Managing Partner. Banking, investment and early-stage company leader. Kent leads financial assessment, commercialization structures, partnerships, and capital formation.

Start a Conversation

Tell us about a technology, partnership, or investment interest.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.